Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Cara Therapeutics Inc. | 10 | 1 | 2 | 0 | €0.70 | €4.62 | 557.368% |
Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €5.97 | €11.05 | 85.169% |
AnaptysBio Inc | 9 | 1 | 4 | 0 | €23.40 | €45.21 | 93.205% |
Patterson Companies Inc. | 7 | 0 | 1 | 0 | €23.80 | €32.18 | 35.219% |
Adverum Biotechnologies Inc. | 7 | 0 | 3 | 0 | €1.38 | €5.60 | 305.913% |
Akebia Therapeutics Inc. | 8 | 2 | 1 | 0 | €1.08 | €3.64 | 238.699% |
Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.00 | €21.66 | -5.830% |
Radnet Inc. | 9 | 3 | 2 | 0 | €54.00 | €54.58 | 1.075% |
Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.82 | €4.16 | 129.267% |
Immunogen Inc. | 5 | 0 | 1 | 0 | €28.97 | - | - |
Anika Therapeutics | 5 | 0 | 1 | 0 | €23.40 | €28.29 | 20.900% |
SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €2.07 | €8.35 | 303.127% |
Viking Therapeutics Inc | 5 | 0 | 2 | 0 | €72.02 | €100.00 | 38.850% |
Syros Pharmaceuticals Inc. | 6 | 1 | 1 | 1 | €5.05 | €13.60 | 169.257% |
Kezar Life Sciences | 5 | 0 | 1 | 0 | €0.72 | €18.56 | 2496.364% |
Cerus Corp. | 4 | 0 | 1 | 0 | €1.89 | €3.26 | 72.291% |
Corvus Pharmaceuticals Inc | 5 | 1 | 1 | 0 | €2.03 | €6.45 | 217.862% |
Healthstream Inc. | 4 | 0 | 0 | 0 | €25.00 | €29.29 | 17.171% |
Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.06 | €19.86 | 227.804% |
Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.80 | €5.00 | 4.167% |
Ocular Therapeutix Inc. | 8 | 5 | 1 | 0 | €5.79 | €12.21 | 111.066% |
Codexis Inc. | 5 | 2 | 1 | 0 | €3.38 | €8.36 | 147.342% |
Novavax Inc. | 6 | 3 | 4 | 2 | €11.50 | €17.59 | 52.975% |
Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €38.51 | €70.00 | 81.795% |
ImmunityBio Inc. | 3 | 0 | 1 | 0 | €7.44 | €10.00 | 34.409% |